SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001415889-14-001849
Filing Date
2014-06-11
Accepted
2014-06-11 16:30:24
Documents
3
Effectiveness Date
2014-06-11

Document Format Files

Seq Description Document Type Size
1 ectedefa14apr_june112014.htm DEFA14A 58568
2 ectedefa14apr_june1120140.jpg GRAPHIC 15736
3 ectedefa14apr_june1120141.jpg GRAPHIC 7128
  Complete submission text file 0001415889-14-001849.txt   91736
Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103
Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100
Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35218 | Film No.: 14904939
SIC: 3845 Electromedical & Electrotherapeutic Apparatus